Navigation Links
Brief exposure to performance-enhancing drugs may be permanently 'remembered' by muscles
Date:10/27/2013

Brief exposure to anabolic steroids may have long lasting, possibly permanent, performance-enhancing effects, shows a study published today [28 October] in The Journal of Physiology.

Previously, re-acquisition of muscle mass with or without steroid use after periods of inactivity has been attributed to motor learning. However, this new data from the University of Oslo suggests that there is a cellular 'memory mechanism' within muscle of brief steroid users.

The team investigated the effects of steroids on muscle re-acquisition in mice and discovered greater muscle mass and more myonuclei which are essential components for muscle fibre function were apparent after returning to exercise.

Professor Kristian Gundersen explains how they carried out the study and the results found:

"Mice were briefly exposed to steroids which resulted in increased muscle mass and number of cell nuclei in the muscle fibres. Three months after withdrawal of the drug (approximately 15% of a mouse's life span) their muscles grew by 30% over six days following load exercise. The untreated mice grew insignificantly."

The findings might have consequences for the exclusion time of doping offenders as brief exposure to anabolic steroids might have long lasting performance-enhancing effects.

Prof Gundersen says:

"The results in our mice may correspond to the effects of steroids lasting for decades in humans given the same cellular 'muscle memory' mechanism. The new results might spur a debate on the current World Anti-Doping Agency (WADA) code in which the maximum exclusion time is currently two years." Additionally, the data suggests that strength training when young might be beneficial later in life since the ability to generate new myonuclei is impaired in the elderly.

Future studies should include human muscles and further investigation into the cellular and molecular mechanism for muscle memory.


'/>"/>

Contact: Lucy Holmes
LHolmes@physoc.org
44-020-726-95727
Wiley
Source:Eurekalert  

Page: 1

Related biology news :

1. NRC authors brief federal agencies on the state of polar regions
2. The Scars of Human Evolution briefing explores physical fallout from 2-footed walking
3. Frontiers news briefs: May 23
4. Frontiers news briefs May 30
5. Frontiers news briefs: June 6
6. Frontiers news briefs: 27 June
7. Frontiers news briefs: July 4
8. Frontiers news briefs: July 23
9. Frontiers news briefs: Aug. 13
10. Biometrics & Technology Sector Leaders Briefing: NXT-ID, Intel, Sony, Facebook, Dell
11. Reproductive health providers should discuss environmental exposure risks with patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Brief exposure to performance-enhancing drugs may be permanently 'remembered' by muscles
(Date:3/20/2017)... 20, 2017 At this year,s CeBIT Chancellor Dr. ... manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with the ... year,s CeBIT partner country. At the largest German biometrics company the two ... face and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/13/2017)... , March 13, 2017 Future of security: Biometric ... ... DERMALOGs Face Matching enables to match face pictures ... the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric Face ...
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today announces that ... uncover insights to support its reporting, help direct future campaigns, and ... youth charity will be using Brandwatch Analytics social listening and analytics ... of the topics and issues that are a priority for its ... "Until recently ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017 NetworkNewsWire Editorial Coverage  ... Cancer remains one ... on health care systems, in terms of costs and resources. ... does the development of innovative and efficient therapies that demonstrate ... many types of cancer treatments, a growing number of patients ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... , March 22, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage ... drug delivery systems, announced today that Dr. ... deliver a presentation titled, "Oral Insulin for Diabetes ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference ...
(Date:3/22/2017)... --  Boston Biomedical , an industry leader in the ... stemness pathways, today announced its Board of Directors has ... Officer, effective April 24, 2017. Ms. ... FACP, who has led Boston Biomedical since he founded ... Biomedical has grown from a "garage startup" without technology ...
Breaking Biology Technology: